IDYA: IDEAYA Biosciences, Inc.
Performance
IDYA +5.92%
Watchlist
Select an item
Summary
IDYA at a glance
IDYA returned +5.92% over the past year and +6.30% a year over five years. Its worst drop in that year was -27.85%, smaller than 62% of stocks on Redstone, and its Sharpe ratio of 0.27 beats 39% of stocks on Redstone. It pays no dividends.
Current Drawdown
-24.60%
Rolling Volatility
46.40%
Actions
Metrics
Risk Indicators
Alpha2.92%
Beta0.93x
Sharpe0.27
Sortino0.40
Omega1.05
Calmar0.21
Martin0.84
Profile
About IDYA
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $3.1B
- Listed
- May 2019
- Employees
- 145
- Headquarters
- South San Francisco, CA
- Website
- ideayabio.com
Comparisons